SCHEMBL5346963

SCHEMBL5346963

CCOO[Si](O)(OOCC)OOCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1345914 0.85
SCHEMBL1348614 0.85
SCHEMBL170226 0.80
SCHEMBL5670515 0.80
SCHEMBL1347635 0.77
SCHEMBL23440179 0.75
SCHEMBL11621979 0.73
SCHEMBL28776974 0.73
SCHEMBL80572 0.72
SCHEMBL27664636 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1293529-B1 Elastomer/reinforcing filler composite GOODYEAR TIRE & RUBBER (US) 2006-12-13 EP claimed
CN-117616084-A Multi-agent type curable composition 株式会社钟化 2024-02-27 CN disclosed
CN-111989379-B Building with wall structure and method for manufacturing wall structure 思美定株式会社 2024-02-20 CN disclosed
EP-3450502-B1 CURABLE COMPOSITION OF THERMOSETTING TYPE KANEKA CORP (JP) 2021-06-09 EP disclosed
CN-110573145-B Mesoporous/hollow silica nanocarrier delivery system for targeted activation of CD44 molecules, method of making same, and uses thereof 北京茵诺医药科技有限公司 2021-02-26 CN disclosed
WO-2021006088-A1 CURABLE COMPOSITION AND CURED PRODUCT 綜研化学株式会社 2021-01-14 WO disclosed
CN-110437126-B Organocatalytic indole non-activated sp3Method and application for asymmetric functionalization of carbon-hydrogen bond 香港科技大学深圳研究院 2020-11-13 CN disclosed
WO-2020196228-A1 CURABLE COMPOSITION AND CURED PRODUCT 株式会社カネカ 2020-10-01 WO disclosed
EP-3115419-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2020-06-17 EP disclosed
EP-3271724-B1 USE OF A STANDARD FOR DETECTING PROTEIN AGGREGATES OF A PROTEIN MISFOLDING DISEASE FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2020-05-27 EP disclosed
US-10072132-B2 Curable composition KANEKA CORPORATION (JP) 2018-09-11 US disclosed
EP-3271724-A1 METHOD FOR PRODUCING A STANDARD FOR DETECTING PROTEIN AGGREGATES OF A PROTEIN MISFOLDING DISEASE, AS WELL AS A STANDARD AND THE USE THEREOF Forschungszentrum Jülich GmbH (DE) 2018-01-24 EP disclosed
EP-3115419-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2017-01-11 EP disclosed
US-20160376420-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2016-12-29 US disclosed
WO-2016146093-A1 METHOD FOR PRODUCING A STANDARD FOR DETECTING PROTEIN AGGREGATES OF A PROTEIN MISFOLDING DISEASE, AS WELL AS A STANDARD AND THE USE THEREOF Forschungszentrum Jülich GmbH (DE) 2016-09-22 WO disclosed
US-9375484-B2 Taxane silicate prodrugs and nanoparticles REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2016-06-28 US disclosed
US-20140213550-A1 SILICATE PRODRUGS AND NANOPARTICLES REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2014-07-31 US disclosed
WO-2012166949-A1 SILICATE PRODRUGS AND NANOPARTICLES REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2012-12-06 WO disclosed
US-7217604-B2 Structure and method for thin box SOI device INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2007-05-15 US disclosed
US-20060172499-A1 STRUCTURE AND METHOD FOR THIN BOX SOI DEVICE INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2006-08-03 US disclosed